NutriBand (NTRB) EPS (Weighted Average and Diluted) (2021 - 2026)
NutriBand's (NTRB) quarterly EPS (Weighted Average and Diluted) came in at -$0.04 in Q1 2026, up 92.16% year-on-year from -$0.02 in Q1 2025, and up 87.5% quarter-over-quarter from -$0.32 in Q4 2025.
NutriBand (NTRB) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
NutriBand has disclosed EPS (Weighted Average and Diluted) across 6 years of filings, most recently posting -$0.04 for Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.04, up 92.16% year-over-year; the trailing twelve-month figure through Jan 2026 was -$2.6 (down 162.63% YoY), and the FY2026 annual result was -$2.58, down 160.61% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.04 for Q1 2026 at NutriBand, up from -$0.32 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.04 in Q1 2026 to a low of -$2.12 in Q3 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.15 (2024), against an average of -$0.31.
- Across the five-year window, EPS (Weighted Average and Diluted) plunged 1313.33% in 2025 and jumped 92.16% in 2026, its largest moves.
- NutriBand's EPS (Weighted Average and Diluted) stood at -$0.14 in 2022, then plunged by 59.62% to -$0.22 in 2023, then surged by 45.45% to -$0.12 in 2024, then plunged by 166.67% to -$0.32 in 2025, then soared by 87.5% to -$0.04 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.04 (Q1 2026), -$0.32 (Q4 2025), and -$2.12 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 0.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.61 |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -0.04 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -0.04 |
| Oct 31, 2025 | -0.32 |
| Jul 31, 2025 | -2.12 |
| Apr 30, 2025 | -0.12 |
| Jan 31, 2025 | -0.51 |
| Oct 31, 2024 | -0.12 |
| Jul 31, 2024 | -0.15 |
| Apr 30, 2024 | -0.21 |
| Jan 31, 2024 | -0.23 |
| Oct 31, 2023 | -0.22 |
| Jul 31, 2023 | -0.11 |
| Apr 30, 2023 | -0.13 |
| Jan 31, 2023 | -0.20 |
| Oct 31, 2022 | -0.14 |
| Jul 31, 2022 | -0.12 |
| Apr 30, 2022 | -0.08 |
| Jan 31, 2022 | -0.48 |
| Oct 31, 2021 | -0.23 |
| Jul 31, 2021 | -0.07 |
| Apr 30, 2021 | -0.05 |